Medicare Enrolled
Dr. Iyad Baker, M.D.
Family Medicine · Ridgefield Park, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Baker from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Baker?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Baker
Dr. Iyad Baker is a family medicine specialist in Ridgefield Park, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Baker performed 1,709 Medicare services across 1,057 unique beneficiaries.
Between the years covered by Open Payments, Dr. Baker received a total of $29,608 from 51 pharmaceutical and/or device companies across 372 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Baker is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 15% volume in NJ
$29,608 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,709
Medicare services
Top 15% in NJ for family medicine
1,057
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~95 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
685 | $73 | $200 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
142 | $106 | $228 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
105 | $11 | $95 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
91 | $142 | $283 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
87 | $12 | $50 |
| COVID-19 immunoassay detection test A laboratory test that uses an immunoassay method to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) through direct visual observation. |
71 | $41 | $50 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
63 | $1 | $26 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
62 | $0 | $47 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
52 | $1 | $11 |
| Influenza virus nucleic acid detection test A laboratory test that uses nucleic acid technology to detect multiple types of influenza virus. |
51 | $94 | $144 |
| Strep A nucleic acid amplification test A laboratory test that uses nucleic acid amplification to detect the presence of Group A Streptococcus bacteria. This method identifies the genetic material of the bacteria to determine if an infection is present. |
50 | $34 | $55 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
46 | $29 | $30 |
| COVID-19 amplified DNA/RNA probe detection A laboratory test that uses amplified DNA or RNA probes to detect the presence of severe acute respiratory syndrome coronavirus 2 (COVID-19) antigen. |
42 | $50 | $150 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
42 | $0 | $26 |
| Flu vaccine, quadrivalent A flu shot containing four strains of the influenza virus to help prevent seasonal influenza infection. |
36 | $73 | $88 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $89 | $243 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
17 | $3 | $15 |
| Routine 12-lead ECG screening A standard 12-lead electrocardiogram performed as part of an initial preventive physical examination. The service includes both the performance of the test and the physician's interpretation and report. |
17 | $8 | $76 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
14 | $16 | $37 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
14 | $177 | $313 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$29,608
Total received (2018-2024)
Avg $4,230/year across 7 years
Top 1% in NJ for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
372
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23,079 (77.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,529 (22.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,709
2023
$807
2022
$946
2021
$23,880
2020
$392
2019
$785
2018
$1,090
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$354
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$218
Novo Nordisk Inc
$200
Intra-Sana Laboratories
$195
Lilly USA, LLC
$113
Amgen Inc.
$84
PFIZER INC.
$72
Gilead Sciences, Inc.
$69
Dexcom, Inc.
$53
Medtronic, Inc.
$51
Abbott Laboratories
$44
Hologic Sales and Service, LLC
$32
Boehringer Ingelheim Pharmaceuticals, Inc.
$32
Phathom Pharmaceuticals, Inc.
$32
GlaxoSmithKline, LLC.
$31
Xeris Pharmaceuticals, Inc.
$28
Optinose US, Inc.
$19
Currax Pharmaceuticals LLC
$18
Exact Sciences Corporation
$18
RGH Enterprises LLC
$17
Paratek Pharmaceuticals, Inc.
$15
Merck Sharp & Dohme LLC
$15
Top 3 companies account for 45.2% of 2024 payments
All-time payments by company (2018-2024) ›
Life Technologies Corporation
$23,058
AstraZeneca Pharmaceuticals LP
$823
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$697
Novo Nordisk Inc
$668
Gilead Sciences, Inc.
$646
PFIZER INC.
$336
GlaxoSmithKline, LLC.
$258
Merck Sharp & Dohme Corporation
$255
Lilly USA, LLC
$215
Horizon Therapeutics plc
$207
Medtronic Vascular, Inc.
$204
Intra-Sana Laboratories
$195
Currax Pharmaceuticals LLC
$138
Abbott Laboratories
$134
Amgen Inc.
$125
Medtronic MiniMed, Inc.
$120
Medtronic, Inc.
$118
Boehringer Ingelheim Pharmaceuticals, Inc.
$116
Janssen Pharmaceuticals, Inc
$101
Amarin Pharma Inc.
$94
Paratek Pharmaceuticals, Inc.
$88
Otsuka America Pharmaceutical, Inc.
$84
Eisai Inc.
$64
Exact Sciences Corporation
$57
Collaborative Care Diagnostics, LLC
$56
Insulet Corporation
$54
Dexcom, Inc.
$53
Antares Pharma, Inc.
$52
Merck Sharp & Dohme LLC
$43
Xeris Pharmaceuticals, Inc.
$42
Novartis Pharmaceuticals Corporation
$42
Sanofi Pasteur Inc.
$39
TOPCON HEALTHCARE SOLUTIONS, INC.
$35
Ultragenyx Pharmaceutical Inc.
$35
Hologic Sales and Service, LLC
$32
Phathom Pharmaceuticals, Inc.
$32
Phadia US Inc.
$32
Daiichi Sankyo Inc.
$31
Horizon Pharma plc
$29
Vertical Pharmaceuticals, LLC
$25
Hikma Pharmaceuticals USA
$21
Meridian Bioscience Inc.
$19
Optinose US, Inc.
$19
Welch Allyn
$19
RGH Enterprises LLC
$17
Valeritas, Inc.
$15
RECORDATI_RARE_DISEASES_INC.
$14
Allergan, Inc.
$14
Teva Pharmaceuticals USA, Inc.
$13
SANOFI-AVENTIS U.S. LLC
$12
McKesson Patient Care Solutions Inc.
$11
Top 3 companies account for 83.0% of all-time payments
Associated products mentioned in payments ›
ABRYSVO · AIRSUPRA · APTIMA · AREXVY · Aimovig · BEVESPI AEROSPHERE · BEXSERO · BOTOX · BREZTRI · Belviq · CHANTIX · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · Cologuard Collection Kit · Crysvita · DUEXIS · Descovy · Dexcom G6 Transmitter · EMGALITY · ENTRESTO · EUCRISA · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 3 · GARDASIL · GARDASIL 9 · GVOKE HYPOPEN · HARMONY · INJECTAFER · INPEN SMART INSULIN DELIVERY SYSTEM · ImmunoCAP · JANUVIA · JARDIANCE · JYNARQUE · KEVEYIS · Kloxxado · LEQVIO · LORZONE · LYRICA · MENACTRA · METHYLPHENIDATE 72 · MINIMED 770G · MINIMED 780G · MOUNJARO · Micra · Minimed 670G System · NOCDURNA · NURTEC ODT · NUZYRA · Omnipod · Otezla · Ozempic · PAXLOVID · PENNSAID · PNEUMOVAX 23 · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · RELTONE 200 MG · Repatha · RetinaVue 100 Imager · Reveal LINQ · Rybelsus · SHINGRIX · SIGNIFOR LAR · SIVEXTRO · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · SYNJARDY · Supera peripheral stent system · TOUJEO · TRELEGY ELLIPTA · Tresiba · Truvada · V-GO · VOQUEZNA · Vascepa · VenaSeal · Victoza · Wegovy · XARELTO · XIFAXAN · Xhance · ZEPBOUND · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (78%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in family medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for family medicine in NJ.
Geographic Context
Family medicine physicians within 10 mi
3,138
Per 100K population
328.7
County median income
$123,715
Nearest hospital
HOLY NAME MEDICAL CENTER
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Baker is a clinical cardiology specialist, with above-average Medicare volume (top 15% in NJ), with speaking/promotional industry engagement in the top 1% of NJ peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Baker experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Baker performed 685 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Baker receive payments from pharmaceutical companies?
Yes. Dr. Baker received a total of $29,608 from 51 companies across 372 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Baker's costs compare to other family medicine physicians in Ridgefield Park?
Dr. Baker's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Baker) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Ridgefield Park
Browse family medicine physicians in Ridgefield Park ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in NJ
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in NJ
Which NJ family medicine physicians receive the most from drug and device companies.
By company
Life Technologies Corporation Payments to Doctors
See all physicians who received payments from Life Technologies Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology